Submission to first editorial decision: 7 days
Submission to decision after review: 51 days
Submission to acceptance: 189 days
Accept to online publication: 24 days

Cell Chemical Biology (originally Chemistry & Biology) is a Cell Press journal that aims to publish and promote the most important advances in chemical biology with integrity, responsiveness, fairness, and friendliness. Chemical biology is a unique discipline that harnesses the power of chemistry to deliver profound molecular insights into biological function and disease etiology and develop solutions for life sciences, biotechnology, and human health.

Cell Chemical Biology encourages submission of basic, translational, and clinical research articles that provide significant conceptual advancements of broad general interest to researchers within the biological sciences, the biomedical sciences, and associated fields. Research areas that we consider within our scope include but are not limited to cancer biology, immunology, cell biology, microbiology, virology, RNA biology, synthetic biology, protein engineering, genome editing, drug discovery, metabolism, and physiology.

We are interested in papers that report molecular mechanisms underlying cellular processes or disease biology; those that report new therapeutics derived from utilizing chemical biology tools; and those that report technologies that perturb, visualize, or measure biological processes. Examples of chemical or molecular tools include but are not confined to nucleic acids and/or their modifications, small molecules, antibodies, biologics, probes, engineered proteins, metabolites, lipids, sugars, and post-translational modifications.

We also welcome submissions reporting significant technical advancements in molecular probes, sensors, tools, and technologies, including a proof-of-principle demonstration that the new methodology/tool will help address important questions in biomedical research that are of interest to our broad readership (from basic scientists to clinicians).

Research
Brief Communication
Resource
Matters Arising
Minireview
Review
Perspective
Meeting Report
Preview

Editor
Dan Nomura, PhD
Dan Nomura is an associate professor in the Departments of Chemistry, Molecular and Cell Biology, and Nutritional Sciences and Toxicology at the University of California, Berkeley. He is also an associate adjunct professor in the Department of Pharmaceutical Chemistry at UCSF. He currently directs the Novartis-Berkeley Center for Proteomics and Chemistry Technologies. He earned his BA in Molecular and Cell Biology and PhD in Molecular Toxicology at UC Berkeley and was a postdoctoral fellow at The Scripps Research Institute in chemical physiology before returning to Berkeley as a faculty member in 2011. Among his honors are selection as a Searle Scholar, American Cancer Society Research Scholar Award, and the Department of Defense Breakthroughs Award. Research in Dan’s laboratory is focused on using chemoproteomic and metabolomic platforms to discover new targets and small molecules for disease therapy. Dan became an Editor of Cell Chemical Biology in 2018.
Eranthie Weerapana, PhD
Eranthie Weerapana is an Associate Professor of Chemistry at Boston College. She received her BS from Yale University, and her PhD from MIT, where she worked with Professor Barbara Imperiali, investigating glycosyltransferases involved in N-linked glycosylation in the gram negative bacterium Campylobacter jejuni. She then performed postdoctoral studies at The Scripps Research Institute, La Jolla, where she worked with Professor Benjamin F. Cravatt to develop chemical-proteomic methods to investigate reactive cysteines in complex proteomes. Her interdisciplinary research program focuses on applying mass-spectrometry methods to identify regulatory cysteine residues in the human proteome and chemical biology approaches to develop covalent small-molecule modulators for these cysteine-mediated protein activities.
Reviews Editor
Bridget Wagner, PhD
Bridget Wagner is the director of pancreatic cell biology and metabolic disease in the Chemical Biology and Therapeutic Sciences Program at the Broad Institute of MIT and Harvard, where she is also an institute scientist. Her group's research focuses on the chemical biology of diabetes, with the aim of identifying small molecules capable of increasing pancreatic beta cell number and function, toward the ultimate goal of discovering new therapeutic approaches for diabetes. Wagner received an A.B. from Harvard College and her Ph.D. from the Department of Molecular and Cellular Biology at Harvard University, working with Stuart Schreiber on developing probe-discovery efforts in an academic setting. Wagner has had an instrumental role in the development of the Broad Chemical Biology Program from its inception in 2003. She is a recipient of the 2008 Type 1 Diabetes Pathfinder Award from the NIH and a Transformative Research Award from the NIH in 2016. 
Associate Editor
Mishtu Dey, PhD
Mishtu Dey is the in-house Editor of Cell Chemical Biology and also holds an appointment as an Adjunct Professor at the University of Iowa. Most recently, she was on the faculty in the University of Iowa's Department of Chemistry, where she developed a federally-funded research program in metalloenzyme structure-function and chemical biology of key metabolic pathway enzymes. She left on good terms pre-tenure to relocate to Boston for personal reasons. She received her PhD in Chemistry from the Indian Institute of Technology Bombay followed by postdoctoral research in mechanistic enzymology at the University of Nebraska-Lincoln and the University of Michigan. She then continued her postdoctoral studies as an HHMI research scientist at MIT in structural enzymology. She is also the in-house Editor of Structure.